急性缺血性卒中诊疗中初始影像选择成本效益研究
本研究基于美国心脏协会AIS诊疗路径推荐构建决策模拟模型,从医疗保健视角比较五种初始影像策略。综合CT与综合MR获得的终生QALYs最高(分别为4.81和4.82),但综合MR相较综合CT的增量成本效益比为$233,000/QALY;阶梯式CT、阶梯式混合及阶梯式先进策略均被综合CT支配。作者结论为在综合卒中中心就诊时行综合CT是最具成本效益的初始影像策略。
要点
- 综合CT与综合MR的终生QALYs分别为4.81与4.82,二者接近。
- 综合MR相较综合CT的增量成本效益比为$233,000/QALY。
- 阶梯式CT、阶梯式混合、阶梯式先进策略被综合CT支配,QALYs更低且成本更高。
核心结论
- 在综合卒中中心,就诊时行综合CT(NCCT+CTA+CTP)是最具成本效益的初始影像策略。
- 综合CT与综合MR的终生QALYs分别为4.81与4.82,综合MR相较综合CT的增量成本效益比为$233,000/QALY。
- 阶梯式CT、阶梯式混合、阶梯式先进策略被综合CT支配,QALYs更低且成本更高。
研究设计与样本
- 研究类型为基于美国心脏协会AIS诊疗路径推荐的决策模拟模型,从医疗保健视角开展成本效益与敏感性分析。
- 目标人群为综合卒中中心疑似前循环AIS且最后已知良好至到达时间0至24小时的患者。
- 比较的五种初始影像策略为:阶梯式CT(就诊时NCCT,仅对筛选患者行CTA±CTP用于MT评估)、阶梯式混合(就诊时NCCT,仅行MRA±MRP用于MT评估)、阶梯式先进(就诊时NCCT+CTA,仅行MR DWI+MRP用于MT评估)、综合CT(就诊时NCCT+CTA+CTP)、综合MR(就诊时MR DWI+MRA+MRP)。
- 模型参数依据循证数据定义。
诊断标准与关键数值
- 成本效益以终生QALYs衡量:综合CT为4.81,综合MR为4.82。
- 综合MR相较综合CT的增量成本效益比为$233,000/QALY。
- 阶梯式CT、阶梯式混合与阶梯式先进策略被综合CT支配,即QALYs更低且成本更高。
临床应用与阅片要点
- 作者结论为在综合卒中中心就诊时行综合CT是最具成本效益的初始影像策略。
- 原文未据此给出其他推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: National guidelines recommend prompt identification of candidates for acute ischemic stroke (AIS) treatment, requiring timely neuroimaging with CT and/or MRI. CT is often preferred because of its widespread availability and rapid acquisition. Despite higher diagnostic accuracy of MRI, it commonly involves complex workflows that could potentially cause treatment time delays. The purpose of this study was to analyze the impact on outcomes of imaging utilization before treatment decisions at comprehensive stroke centers for patients presenting with suspected AIS in the anterior circulation with last-known-well-to-arrival time 0 to 24 hours.
METHODS: A decision simulation model based on the American Heart Association's recommendations for AIS care pathways was developed from a health care perspective to compare initial imaging strategies: (1) stepwise-CT: noncontrast CT (NCCT) at the time of presentation, with CT angiography (CTA) ± CT perfusion (CTP) only in select patients (initial imaging to exclude hemorrhage and extensive ischemia) for mechanical thrombectomy (MT) evaluation; (2) stepwise-hybrid: NCCT at the time of presentation, with MR angiography (MRA) ± MR perfusion (MRP) only for MT evaluation; (3) stepwise-advanced: NCCT + CTA at presentation, with MR diffusion-weighted imaging (MR DWI) + MRP only for MT evaluation; (4) comprehensive-CT: NCCT + CTA + CTP at the time of presentation; and (5) comprehensive-MR: MR DWI + MRA + MRP at the time of presentation. Model parameters were defined using evidence-based data. Cost-effectiveness and sensitivity analyses were performed.
RESULTS: The cost-effectiveness analyses revealed that comprehensive-CT and comprehensive-MR yield the highest lifetime quality-adjusted life-years (QALYs) (4.81 and 4.82, respectively). However, the incremental cost-effectiveness ratio of comprehensive-MR is $233,000/QALY compared with comprehensive-CT. Stepwise-CT, stepwise-hybrid, and stepwise-advanced strategies are dominated, yielding lower QALYs and higher costs compared with comprehensive-CT.
CONCLUSIONS: Performing comprehensive-CT at presentation is the most cost-effective initial imaging strategy at comprehensive stroke centers.
引用
- Martinez G, Katz JM, Pandya A, et al. Cost-Effectiveness Study of Initial Imaging Selection in Acute Ischemic Stroke Care. J Am Coll Radiol. 2020. PMID: 33387454. doi:10.1016/j.jacr.2020.12.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。